Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

β′-COP Inhibitors

The chemical class known as β'-COP inhibitors comprises a diverse group of organic compounds that share a common aim: the modulation of the activity of β'-COP, a critical component of the COPI (coatomer protein complex I) machinery involved in intracellular vesicle trafficking and protein transport. These inhibitors are designed with precision to perturb the function of β'-COP and, consequently, the processes governed by the COPI complex. β'-COP is pivotal in the formation of vesicles that facilitate the transport of proteins within cells, contributing to the maintenance of cellular compartments and organelles. The uniqueness of the β'-COP inhibitors class stems from their specific chemical structures, which are strategically designed to interact with β'-COP or its associated molecules. By interfering with β'-COP's function, these inhibitors disrupt vesicle formation, which impacts the trafficking of proteins within cells. This inhibition often occurs through the modulation of molecules such as ADP-ribosylation factor 1 (ARF1) and Golgi-specific Brefeldin A resistance factor 1 (GBF1), both of which are intricately involved in COPI vesicle assembly and protein transport processes.

Researchers employ β'-COP inhibitors as valuable tools to investigate the cellular consequences of inhibiting COPI vesicle formation. Through the alteration of vesicular trafficking patterns, these inhibitors enable the examination of the impacts on organelle integrity, intercellular communication, and protein compartmentalization. The chemical class of β'-COP inhibitors has been instrumental in unraveling the intricacies of cellular transport processes, facilitating a deeper understanding of the role of COPI-mediated trafficking in cellular function. By unraveling the complexities of these processes, researchers gain insights into the fundamental mechanisms underlying cellular organization and compartmentalization.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

A naturally occurring compound that disrupts COPI vesicle formation by inhibiting ADP-ribosylation factor 1 (ARF1), which is involved in vesicle budding. This disruption affects β'-cop function.

SecinH3

853625-60-2sc-203260
5 mg
$278.00
6
(1)

A synthetic compound that inhibits the exchange factor GBF1 (Golgi-specific Brefeldin A resistance factor 1), leading to the inhibition of COPI vesicle formation and β'-cop-mediated transport.

2-(Benzoylcarbamothioylamino)-5,5-dimethyl-4,7-dihydrothieno[2,3-c]pyran-3-carboxylic Acid

314042-01-8sc-503400
10 mg
$300.00
(0)

A compound that selectively inhibits the binding of β'-cop to membranes, thus interfering with COPI vesicle formation and subsequent protein trafficking.

Exo2

304684-77-3sc-215011
sc-215011A
5 mg
25 mg
$89.00
$288.00
1
(0)

A molecule that disrupts COPI vesicle formation by inhibiting ARF1 activation. This inhibition affects β'-cop function and protein transport.

Cyclopiazonic Acid

18172-33-3sc-201510
sc-201510A
10 mg
50 mg
$176.00
$624.00
3
(1)

A mycotoxin that indirectly affects COPI vesicle formation by disturbing calcium homeostasis, leading to ER stress and potentially impacting β'-cop-mediated processes.

Golgicide A

1005036-73-6sc-215103
sc-215103A
5 mg
25 mg
$191.00
$683.00
11
(1)

This compound inhibits GBF1 activity, resulting in the disruption of COPI vesicle formation and interfering with β'-cop-mediated vesicle trafficking.

Aurintricarboxylic Acid

4431-00-9sc-3525
sc-3525A
sc-3525B
sc-3525C
100 mg
1 g
5 g
10 g
$20.00
$32.00
$48.00
$94.00
13
(1)

While mainly recognized for its ability to inhibit nucleic acid-protein interactions, this compound can also interfere with COPI vesicle formation and β'-cop functions.

Exo1

461681-88-9sc-200752
sc-200752A
10 mg
50 mg
$84.00
$297.00
4
(1)

Similar to Exo2, Exo1 disrupts COPI vesicle formation by inhibiting ARF1 activation, subsequently affecting β'-cop functions and protein transport.

CGP 37157

75450-34-9sc-202097
sc-202097A
5 mg
25 mg
$115.00
$463.00
3
(1)

Although primarily recognized as a mitochondrial sodium/calcium exchanger inhibitor, CGP-37157 also impacts COPI vesicle formation and β'-cop functions through its effects on calcium homeostasis.